ABRAXAS1 and breast carcinoma: Although the results of our study did not provide evidence that rare variants in ABRAXAS are associated with increased breast cancer risk in the populations studied, we cannot rule out the possibility that rare mutations in ABRAXAS may be involved in some high-risk families with more specific phenotypes.